Biotech News
Related news
LUNGPulmonx2026-09-01 20:05 EST
Pulmonx Corporation Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
LUNGPulmonx2026-07-29 20:05 EST
Pulmonx Reports Second Quarter 2026 Financial Results
SENSSenseonics2026-09-10 12:00 EST
Senseonics To Participate in Upcoming Institutional Investor Conferences
DCTHDelcath Systems2026-08-31 20:01 EST
Delcath Systems to Participate in Upcoming Investor Conferences
LMATLeMaitre Vascular2026-08-27 20:51 EST
LeMaitre to Participate at Upcoming Investor Conferences in September
ICUIICU Medical2026-08-27 12:30 EST
ICU Medical to Participate in Upcoming Investor Conferences
PAVMPAVmed2026-08-04 12:30 EST
Lucid Diagnostics to Participate in Upcoming Investor Conferences
AORTArtivion2026-07-28 20:10 EST
Artivion to Participate in Upcoming Investor Conferences
ANGOAngioDynamics2026-07-28 12:30 EST
AngioDynamics to Participate in Upcoming Investor Conferences
ATRCAtriCure2026-07-27 12:00 EST
AtriCure to Participate at Upcoming Investor Conferences
Pulmonx
Minimally Invasive COPD Treatment Pulmonx develops minimally invasive technologies for patients with severe emphysema and chronic obstructive pulmonary disease who remain highly symptomatic despite medical therapy. Zephyr Endobronchial Valve The Zephyr Valve is an implantable bronchoscopic device that occludes selected diseased lung...
Recent company news
LUNGPulmonx2026-09-01 20:05 EST
Pulmonx Corporation Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
LUNGPulmonx2026-08-27 20:05 EST
Pulmonx to Participate in Upcoming Investor Conferences
LUNGPulmonx2026-07-29 20:05 EST
Pulmonx Reports Second Quarter 2026 Financial Results
LUNGPulmonx2026-07-28 20:05 EST
Pulmonx to Present at the Canaccord Genuity 46th Annual Growth Conference
LUNGPulmonx2026-07-15 20:05 EST
Pulmonx to Report Second Quarter 2026 Financial Results on July 29, 2026
Stock data
- Close
- 1.98 USD
- Market cap
- 68M USD
- Exchange
- NASDAQ
- Sector
- MedTech
- Location
- United States